ARYA Sciences Acquisition Corp IV
ARYD · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $3 | $1 | $0 |
| SG&A Expenses | $1 | $3 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $3 | $1 | $0 |
| Operating Income | -$1 | -$3 | -$1 | -$0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $1 | $1 | $0 |
| Pre-Tax Income | -$0 | -$2 | -$0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$2 | -$0 | $0 |
| % Margin | – | – | – | – |
| EPS | -0.032 | -0.28 | -0.061 | 0.051 |
| % Growth | 88.7% | -356.8% | -219.3% | – |
| EPS Diluted | -0.032 | -0.28 | -0.061 | 0.051 |
| Weighted Avg Shares Out | 8 | 8 | 7 | 7 |
| Weighted Avg Shares Out Dil | 8 | 8 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $0 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $0 |
| EBITDA | -$1 | $0 | -$1 | -$0 |
| % Margin | – | – | – | – |